The Cooper (LTS:0I3I) Cash And Cash Equivalents : $135 Mil (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is The Cooper Cash And Cash Equivalents?

The Cooper's quarterly cash and cash equivalents increased from Jul. 2023 ($117.30 Mil) to Oct. 2023 ($120.80 Mil) and increased from Oct. 2023 ($120.80 Mil) to Jan. 2024 ($135.20 Mil).

The Cooper's annual cash and cash equivalents increased from Oct. 2021 ($95.90 Mil) to Oct. 2022 ($138.20 Mil) but then declined from Oct. 2022 ($138.20 Mil) to Oct. 2023 ($120.80 Mil).

The Cooper Cash And Cash Equivalents Historical Data

The historical data trend for The Cooper's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Cooper Cash And Cash Equivalents Chart

The Cooper Annual Data

Trend

Oct14

Oct15

Oct16

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Cash And Cash Equivalents

Get a 7-Day Free Trial

89.00

115.90

95.90

138.20

120.80

The Cooper Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Cash And Cash Equivalents	Get a 7-Day Free Trial															118.20	111.90	117.30	120.80	135.20

The Cooper Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

The Cooper (LTS:0I3I) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

The Cooper Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of The Cooper's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (LTS:0I3I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines